Wordt geladen...
ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells
BACKGROUND: Platinum drugs, including cisplatin, are a frontline therapeutic in ovarian cancer treatment and acquired resistance to these agents is a major contributor to ovarian cancer morbidity and mortality. In this study a novel glycosylation-dependent mechanism for cisplatin resistance is descr...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3637436/ https://ncbi.nlm.nih.gov/pubmed/23578204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1757-2215-6-25 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|